Cost Analysis of Clinical Compounding in Saudi Arabia: Anti-tuberculosis Pediatrics Formulations | Zendy

Yousef Ahmed Alomi | Zendy; Faiz A Bahadig | Zendy; Malika Alhadab | Zendy; Mona Lubbad | Zendy; Ebtesam Nazal | Zendy; Mayssa Ahmed Assiri | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cost Analysis of Clinical Compounding in Saudi Arabia: Anti-tuberculosis Pediatrics Formulations

Author(s) -

Yousef Ahmed Alomi,

Faiz A Bahadig,

Malika Alhadab,

Mona Lubbad,

Ebtesam Nazal,

Mayssa Ahmed Assiri

Publication year - 2019

Publication title -

international journal of pharmacology and clinical sciences

Language(s) - English

Resource type - Journals

ISSN - 2278-0068

DOI - 10.5530/ijpcs.2019.8.39

Subject(s) - christian ministry , medicine , pharmacy , clinical pharmacy , health care , family medicine , pharmacist , pediatrics , philosophy , theology , economics , economic growth

Yousef Ahmed Alomi* , General Administration of Pharmaceutical Care, Ministry of Health, Riyadh, Saudi Arabia. Malika Alhadab, Head, Pharmacy Services, Alyamma Hopsital, Ministry of Health, Riyadh, Saudi Arabia. Faiz A. Bahadig, Informatics Pharmacist, Pharmaceutical Care Department, King Abdul-Aziz Medical, City-WR-Jeddah, Ministry of National Guard, Saudi Arabia. Mona Lubbad, Former Head, Extemporaneous Preparation Unit, Pharmacy services, Alyamma Hopsital, Ministry of Health, Riyadh, Saudi Arabia. Ebtesam Nazal, Head, Extemporaneous Preparation Unit, Pharmacy Services, Alyamma Hopsital, Ministry of Health, Riyadh, Saudi Arabia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research